HEBERT, A.; GLAAB, D.; SCHREIBER, R. A Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, n. 2, p. 171, 2019. DOI: 10.25251/skin.3.2.11. Disponível em: https://jofskin.org/index.php/skin/article/view/528. Acesso em: 22 jul. 2024.